American Oncology Network
corporate_fare Company Profile
American Oncology Network (OTC:AONC) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 2 items for AONC at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-21, rated 9/10. Across its 2 most recent items scored 7 or higher, the top rating is 9/10, with 1 rated 8 or above.
Recent high-impact activity:
- Cencora to Buy American Oncology Network in $2.4B Deal
- American Oncology Network Partners with Colla Health to Expand Behavioral Health Services
Financial Snapshot
Short Interest & Short Volume
1.27 days to coverFINRA reported short interest of 11,688 shares in AONC as of the October 30, 2026 settlement, a 37.5% increase from the prior period — about 1.3 days to cover at its recent average daily volume.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.